Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Clinical thoracic ultrasound plays an important role in the exploration, diagnosis and follow-up of thoracic pathologies.
The COVID (Coronavirus Disease) epidemic is leading to a large influx of patients in the emergency department with respiratory disorders. The rapid diagnosis of respiratory disorders in infected patients is important for further management.
Chest ultrasound has already demonstrated its value in the diagnosis of pneumonia in the emergency department with superiority over chest X-ray.
However, there is little data on the thoracic ultrasound semiology of viral pneumonia in general and of COVID in particular.
Chest ultrasound has already shown its value in the diagnosis of pneumonia in the emergency department with superiority over chest X-ray.
However, there is little data on the thoracic ultrasound semiology of viral pneumonia in general and of COVID in particular.
Peng reported data from 20 patients and compared them to chest CT. The abnormalities are a thickening of the pleuropneumonia line, an interstitial syndrome with B lines, corresponding to frosted glass opacities, confluent B lines (snowstorm appearance) corresponding to interstitial infiltrate, sub-pleural alveolar opacities corresponding to sub-pleural condensations, more frank alveolar images corresponding to alveolar opacities. A multifocal aspect was associated with involvement of more than 2 lobes. However, the frequency of these abnormalities as well as the sensitivity of the echo are not detailed in this article.
Another Italian article describes a clinical case of COVID-19 pneumonia with sub-pleural involvement and irregularity of the pleuro-pulmonary line.
Clinical thoracic ultrasound has a major potential interest during the COVID epidemic: available at the patient's bedside, avoiding the need to move around, feasible for the physician during his visit, easy to clean especially if ultraportable devices are used, fast and not exposing the staff any more than the usual clinical examination.
In order to determine whether this technique is useful in the management of infected patients or patients suspected of COVID-19 infection with respiratory signs, we propose a descriptive prospective study evaluating the ultrasound semiology of COVID-19 pneumonia and the interest of ultrasound in the evolutionary follow-up of these patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patient hospitalised with COVID-19 infection | Patients admitted to hospital with proven COVID-19 infection with respiratory signs warranting a chest CT scan |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No special intervention | Other | No special intervention : Ultrasound data will be collected |
|
| Measure | Description | Time Frame |
|---|---|---|
| Characteristics of pulmonary ultrasound for Covid-19 patients | description of ultrasound abnormalities for Covid-19 patients | Day one |
| Measure | Description | Time Frame |
|---|---|---|
| Characteristics of pulmonary ultrasound for Covid-19 patients | description of ultrasound abnormalities for Covid-19 patients | Day 3 |
| Characteristics of pulmonary ultrasound for Covid-19 patients |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patient admitted to hospital with proven COVID-19 infection with respiratory signs and who need an hospitalization
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Amiens | Amiens | 80054 | France | |||
| CH de la Côte Basque |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
description of ultrasound abnormalities for Covid-19 patients
| Day 14 |
| Charateristics of pulmonary CT-scan for Covid-19 patients | description of CT-scan abnormalities for Covid-19 patients | Day 1 |
| Charateristics of pulmonary CT-scan for Covid-19 patients | description of CT-scan abnormalities for Covid-19 patients | Day 3 |
| Charateristics of pulmonary CT-scan for Covid-19 patients | description of CT-scan abnormalities for Covid-19 patients | Day 14 |
| Bayonne |
| 64109 |
| France |
| CHU Ambroise Paré | Boulogne-Billancourt | 92104 | France |
| CHU Caen | Caen | 14033 | France |
| CHG de Chambery | Chambéry | 73000 | France |
| Centre Hospitalier Intercommunal de Créteil | Créteil | 94000 | France |
| CHU de Limoges | Limoges | 87000 | France |
| APHM - Hopital Nord | Marseille | 13015 | France |
| CHU de Nancy | Nancy | 54035 | France |
| CHU Nîmes | Nîmes | 30029 | France |
| CHR Orléans | Orléans | 45100 | France |
| CHU Cochin | Paris | 75679 | France |
| CHU Poitiers | Poitiers | 86021 | France |
| CHU Rouen | Rouen | 76038 | France |
| CH Saint-Quentin | Saint-Quentin | 02321 | France |
| CHU Larrey - Toulouse | Toulouse | 31059 | France |
| CHU de Tours | Tours | 37000 | France |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
Not provided
Not provided